{"name": "Allecra Therapeutics",
 "permalink": "allecra-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/allecra-therapeutics",
 "homepage_url": "http://allecra.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2013,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@allecra.com",
 "phone_number": "41-79-592-2005",
 "description": "Biopharmaceutical company",
 "created_at": "Sat Apr 20 10:56:00 UTC 2013",
 "updated_at": "Sat Apr 20 11:01:15 UTC 2013",
 "overview": "\u003Cp\u003EAllecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       105],
      "assets/images/resized/0025/3399/253399v1-max-150x150.jpg"],
     [[150,
       105],
      "assets/images/resized/0025/3399/253399v1-max-250x250.jpg"],
     [[150,
       105],
      "assets/images/resized/0025/3399/253399v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac15M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://finance.yahoo.com/news/edmond-rothschild-investment-partners-co-060202368.html",
    "source_description": "Edmond de Rothschild Investment Partners co-leads the \u20ac15 Million Series A financing of Allecra Therapeutics with its new fund BioDiscovery 4",
    "raised_amount": 15000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Edmond de Rothschild Investment Partners",
         "permalink": "edmond-de-rothschild-investment-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "EMBL Ventures",
         "permalink": "embl-ventures",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0006/8288/68288v1-max-150x150.jpg"],
             [[191,
               67],
              "assets/images/resized/0006/8288/68288v1-max-250x250.jpg"],
             [[191,
               67],
              "assets/images/resized/0006/8288/68288v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}